tiprankstipranks

Mirum Pharmaceuticals partner Takeda receives approval for Livmarli in Japan

Mirum Pharmaceuticals partner Takeda receives approval for Livmarli in Japan

Mirum Pharmaceuticals (MIRM) announced that its partner, Takeda (TAK), has received approval by the Japanese Ministry of Health, Labour, and Welfare for Livmarli oral solution for the treatment of cholestatic pruritus in patients with Alagille syndrome and Progressive Familial Intrahepatic Cholestasis in Japan.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue